Simple and Practical Mental Health

The BEST resource for mental health clinicians

  • REVIEWS
  • MENUS
  • RESOURCES
    • Side effect handouts
    • Patient handouts: Main page
    • How to find treatment resources
    • Rating scales and questionnaires for mental health clinicians
    • BEST books
    • BEST apps/ websites
  • NEWS
  • QUESTIONS?
  • DAILY EMAILS
  • FAQ
  • LOG IN
  • JOIN

Activity of cariprazine (Vraylar®) on dopamine D3 and D2 receptors

This page was last reviewed/updated on January 8, 2023. Note: This article is not of direct practical use. It provides background information that may be useful when considering whether or not to prescribe cariprazine to a particular patient. Cariprazine (brand name Vraylar®) is a second-generation (atypical) antipsychotic. For basic information about cariprazine, please see the…

This content is for Monthly Membership and Yearly Membership members only.
Register
Already a member? Log in here

Share this:

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email

Follow us on social media

  • Facebook
  • LinkedIn
  • Twitter

Copyright 2016 to 2025: Simple and Practical Medical Education, LLC. All rights reserved.